Overview and Scope
Antimicrobial susceptibility testing (AST) is a laboratory procedure done by clinical laboratory professionals to identify which antimicrobial specimen is specifically effective for individual patients. The antimicrobial susceptibility testing market consists of sales of antimicrobial susceptibility testing by entities (organizations, sole traders and partnerships) that are engaged in laboratory services that provide antimicrobial susceptibility testing.
Sizing and Forecast
The antimicrobial susceptibility testing market size has grown strongly in recent years. It will grow from $4.03 billion in 2023 to $4.33 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to rise in healthcare expenditure, aging population, awareness and education, regulatory support, economic growth.
The antimicrobial susceptibility testing market size is expected to see strong growth in the next few years. It will grow to $5.46 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to increasing prevalence of drug-resistant infections, rise in healthcare infrastructure, growing emphasis on drug discovery, rise in disposable income. Major trends in the forecast period include automation and robotics, ai and machine learning, multiplexing, telemedicine integration, rapid ast methods.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/antimicrobial-susceptibility-testing-global-market-report
The antimicrobial susceptibility testing market covered in this report is segmented –
1) By Type: Antibacterial Testing, Antifungal Testing, Antiparasitic Testing, Other Types
2) By Products: Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, Consumables
3) By Application: Diagnostics, Drug Discovery and Development, Epidemiology, Other Applications
4) By End User: Hospitals And Diagnostic Centers, Pharmaceutical And Biotechnology Companies, Research And Academic Institutes, Clinical Research Organizations (CROs)
North America was the largest region in the antimicrobial susceptibility testing market in 2023. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the antimicrobial susceptibility testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=4026&type=smp
Major Driver Impacting Market Growth
The rising incidence of infectious diseases globally contributed to the growth of the antimicrobial susceptibility testing market. Infectious diseases are caused by organisms like bacteria, viruses, fungi and parasites. Diseases caused by bacteria are bacterial pneumonia, tuberculosis, the virus smallpox, AIDS and others. According to World Health Organization (WHO), in 2021 , an estimated 10.6 million people are infected with tuberculosis globally, 1.6 million died, and 1.5 million people acquired HIV in 2021 while 650,000 people lost lives due to it. This increase in the incidence of infected people boosted the use of susceptibility testing of the organisms to develop the most effective drugs and this, in turn, drove the market for antimicrobial susceptibility testing.
Key Industry Players
Major companies operating in the antimicrobial susceptibility testing market include BioMérieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Accelerate Diagnostics Inc., Hi-Media Laboratories, Creative Diagnostics, Merck KGaA, Roche Diagnostics Limited, Alifax Holding S.p.A., Synbiosis Ltd., Zhuhai DL Biotech Co. Ltd., Mast Group Ltd., ELITechGroup, Genefluidics Inc., Condalab, QuantaMatrix Inc., Bruker Corporation, Eurofins Scientific SE, Liofilchem s.r.l., Hardy Diagnostics, Micromax Technologies, Bioanalyse GmbH, Lab M Limited, Microbiologics Inc., Quidel Corporation, R-Biopharm AG, SSI Diagnostica A/S, VWR International LLC, ZeptoMetrix Corporation
The antimicrobial susceptibility testing market report table of contents includes:
1. Executive Summary
2. Antimicrobial Susceptibility Testing Market Characteristics
3. Antimicrobial Susceptibility Testing Market Trends And Strategies
4. Antimicrobial Susceptibility Testing Market – Macro Economic Scenario
…
31. Global Antimicrobial Susceptibility Testing Market Competitive Benchmarking
32. Global Antimicrobial Susceptibility Testing Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Antimicrobial Susceptibility Testing Market
34. Antimicrobial Susceptibility Testing Market Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
